The FDA has authorized several antiviral medications, including Paxlovid, to treat mild to moderate COVID-19, especially in people who are more likely to get very sick. These medications work by reducing the ability of the COVID-19 virus to multiply in the body.
Antiviral medications must be started within 5-7 days of when a person first experiences symptoms. If you think you have COVID and think you are at high risk for developing severe COVID, contact your provider right away. People who are at increased risk for severe COVID include people aged 50 and over, people who aren’t up to date on COVID-19 vaccinations, and those with certain medical conditions, including chronic lung disease, heart disease, or a weakened immune system. People with compromised immune systems – such as those who have had a bone marrow transplant or are taking immunosuppressing medication – may be eligible for convalescent plasma treatment. This treatment involves a blood transfusion to give the person antibodies to fight off the infection.
Supporting Links:
https://www.cdc.gov/covid/treatment/index.html
https://www.mayoclinic.org/tests-procedures/convalescent-plasma-therapy/about/pac-20486440
https://www.yalemedicine.org/news/13-things-to-know-paxlovid-covid-19
https://www.paxlovid.com/who-can-take#:~:text=If%20you%20have%20mild%2Dto%2Dmoderate%20COVID%2C%20have%20had,be%20an%20option%20for%20you
